Dr. Conn joined Pharvaris in 2017, with over 15 years’ experience in the biopharmaceutical industry. Previously, he had served PTC Therapeutics since 2001, initially in Research and subsequently in positions of increasing responsibility in the Business Development group starting from its inception, ultimately leading Business Development for the organization.
During this time, Morgan was instrumental to a variety of corporate transactions with leading pharma, biotech, and academic organizations, and supported private and public financing events. In 2017, he founded CallisBio, a biopharma business and corporate development consulting firm.
Early in his career, Morgan served as an Assistant Professor in Chemistry at Amherst College, with a cross appointment in the Graduate Molecular and Cellular Biology program at the University of Massachusetts (Amherst). Morgan trained in organic chemistry and chemical biology. He holds a B.Sc. from the University of Toronto, a Ph.D. from the Massachusetts Institute of Technology, and studied as a Research Fellow of the Miller Institute for Basic Research in Science at the University of California, Berkeley.